Menu ×

HEALTHCARE & PHARMACEUTICAL

North America Sterile Tubing Welders Market Segmentation by Mode (Automatic and Manual); by Connection Type (Dry-Dry Connection, Wet-Dry Connection, Wet-Wet Connection, and Multiple Use); by Applications (Component Pooling, Quality Control Sampling, Leukoreduction, Fluid Replacement, Pathogen Reduction, Cell Washing & Freezing, and Others); by End-User (Hospitals, Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Blood Banks) – Demand Analysis & Opportunity Outlook 2019-2028

  • Text Size:

Extensive insights into the Growth of Sterile Tubing Welders Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

  • April 27, 2017: Machine Solutions Inc., the parent company of Vante Inc., announced the acquisition of SEBRA, the leading manufacturer of tube sealing equipment, from Haemonetics Corporation.

  • April 13, 2018: Saint-Gobain Performance Plastics announced the acquisition of the pharmaceutical business of Micro Hydraulics. Micro Hydraulics, an Irish company, is known for supplying and manufacturing single-use fluid handling components and systems in high performance plastics for use in the pharmaceutical and biopharmaceutical industries.

North America Sterile Tubing Welders Market 2019-2028

The North America sterile tubing welders market attained revenue of USD 1120 Million in 2019 and is estimated to garner USD 1517 Million in 2028 by growing at a CAGR of 4.40% over the forecast period, i.e., 2020-2028. The rapidly growing demand for sterile tubes, along with the rising need for hygienic environment in medical sciences, and the technological advancements in the healthcare industry are some of the major factors anticipated to drive the growth of the market in the coming years. Additionally, surge in need for blood platelets and plasma, along with the growing awareness for blood donation in the North America region, is anticipated to drive the demand for sterile tubing methodologies, and in turn drive the market growth during the forecast period. It is estimated that around 35000 units of red blood cells are required every single day in the United States. Further, close to 10000 units of plasma and about 7000 units of platelets are needed in the nation. On the other hand, the growing incidences of blood disorders, such as sickle cell disease, which affects around 1 million people in the United States, is also anticipated to contribute to the market growth.

Sterile Tubing Welders Market Graph

Growth Drivers and Challenges Impacting the Growth of the North America Sterile Tubing Welders Market

Growth Drivers

  • Growing Demand for Sterile Tubing from End-Users
  • Growing Healthcare Expenditure
  • Increasing Prevalence of Chronic Diseases

Challenges

  • Availability of Low-Cost Alternatives
  • Stringent Government Norms for Manufacturing Sterile Tubing Welders

North America Sterile Tubing Welders Market Segmentation Synopsis

The North America sterile tubing welders market is segmented on the basis of connection type into dry-dry connections, wet-dry connections, wet-wet connections, and multiple use. Amongst these segments, the wet-dry connections segment is anticipated to register the largest market share in the year 2021 and further touch USD 699.5 Million by the end of 2028. The segment is also anticipated to grow with the highest CAGR of 5.01% during the forecast period. CLICK TO DOWNLOAD SAMPLE REPORT

The market is also segmented based on mode into automatic and manual. Among these segments, the automatic segment is projected to grab the largest market share by the end of 2028 and further grow with a CAGR of 4.57% during the forecast period. The automatic sterile tubing welders are designed for biopharmaceutical process applications. These devices are equipped with automatically controlled heating operation and are much more efficient than a manual sterile tubing welder.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the North America sterile tubing welders market that are included in our report are Terumo BCT, Inc., Sartorius AG, GenesisBPS, MGA Technologies, Cytiva (Global Life Sciences Solutions USA LLC), Vante Biopharm/Sebra, Pall Corporation, Saint-Gobain Performance Plastics, and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

  1. Introduction
    1. Market Definition
    2. Market Segmentation
    3. Product overview
  2. Research Methodology
    1. Research process
    2. Primary research
      1. Sterile Tubing Welders Manufacturers
      2. Distributors
      3. End-users
    3. Secondary research
    4. Market size estimation
  3. Executive Summary- North America Sterile Tubing Welders Market
  4. Analysis of Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  5. Regulatory & Standards Landscape
  6. Pricing Analysis
  7. Impact of COVID-19 on the Sterile Tubing Welders Market
    1. Impact on the overall market
    2. Impact on the manufacturing
    3. Impact on the supply & distribution
    4. Impact on the key market players
    5. Impact on overall price trend
    6. Market impact analysis in 2020 (quarter wise) w.r.t covid-19 pandemic (USD Millions)
  8. Competitive Structure
    1. Terumo BCT, Inc.
    2. Sartorius AG
    3. GenesisBPS
    4. MGA Technologies
    5. Cytiva (Global Life Sciences Solutions USA LLC)
    6. Vante Biopharm/Sebra
    7. Pall Corporation
    8. Saint-Gobain Performance Plastics
  9. North America Sterile Tubing Welders Market Outlook
    1. By value (USD Million)
  10. North America Sterile Tubing Welders Market Segmentation Analysis 2019-2028
    1. By mode
      1. Automatic, 2019-2028F (USD Million)  
      2. Manual, 2019-2028F (USD Million)
    2. By connection type
      1. Dry-dry connections, 2019-2028F (USD Million)
      2. Wet-dry connections, 2019-2028F (USD Million)
      3. Wet-wet connections, 2019-2028F (USD Million)
    3. By end-user & application
      1. Hospitals, 2019-2028F (USD Million)
        1. Component pooling, 2019-2028F (USD Million)
        2. Quality control sampling, 2019-2028F (USD Million)
        3. Leukoreduction, 2019-2028F (USD Million)
        4. Fluid replacement, 2019-2028F (USD Million)
        5. Pathogen reduction, 2019-2028F (USD Million)
        6. Cell washing & freezing, 2019-2028F (USD Million)
        7. Others, 2019-2028F (USD Million)
      2. Biotechnology & pharmaceutical companies, 2019-2028F (USD Million)
        1. Component pooling, 2019-2028F (USD Million)
        2. Quality control sampling, 2019-2028F (USD Million)
        3. Leukoreduction, 2019-2028F (USD Million)
        4. Fluid replacement, 2019-2028F (USD Million)
        5. Pathogen reduction, 2019-2028F (USD Million)
        6. Cell washing & freezing, 2019-2028F (USD Million)
        7. Others, 2019-2028F (USD Million)
      3. Diagnostic laboratories, 2019-2028F (USD Million)
        1. Component pooling, 2019-2028F (USD Million)
        2. Quality control sampling, 2019-2028F (USD Million)
        3. Leukoreduction, 2019-2028F (USD Million)
        4. Fluid replacement, 2019-2028F (USD Million)
        5. Pathogen reduction, 2019-2028F (USD Million)
        6. Cell washing & freezing, 2019-2028F (USD Million)
        7. Others, 2019-2028F (USD Million)
      4. Blood banks, 2019-2028F (USD Million)
        1. Component pooling, 2019-2028F (USD Million)
        2. Quality control sampling, 2019-2028F (USD Million)
        3. Leukoreduction, 2019-2028F (USD Million)
        4. Fluid replacement, 2019-2028F (USD Million)
        5. Pathogen reduction, 2019-2028F (USD Million)
        6. Cell washing & freezing, 2019-2028F (USD Million)
        7. Others, 2019-2028F (USD Million)
      5. Research organizations, 2019-2028F (USD Million)
        1. Component pooling, 2019-2028F (USD Million)
        2. Quality control sampling, 2019-2028F (USD Million)
        3. Leukoreduction, 2019-2028F (USD Million)
        4. Fluid replacement, 2019-2028F (USD Million)
        5. Pathogen reduction, 2019-2028F (USD Million)
        6. Cell washing & freezing, 2019-2028F (USD Million)
        7. Others, 2019-2028F (USD Million)

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved